A phase I/II study of GTI-2040 and capecitabine combination therapy in patients with advanced metastic renal cell carcinoma ( mRCC ) - (Lorus Therapeutics, Inc.)

Project: Research

Status	Finished
Effective start/end date	01/13/03 → 01/12/07

Project Details